Cargando…
Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851780/ https://www.ncbi.nlm.nih.gov/pubmed/35177093 http://dx.doi.org/10.1186/s13000-022-01207-6 |
_version_ | 1784652894016897024 |
---|---|
author | Kogan, Evgeniya Berezovskiy, Yuriy Blagova, Olga Kukleva, Anna Semyonova, Lyudmila Gretsov, Evgeniy Ergeshov, Atadzhan |
author_facet | Kogan, Evgeniya Berezovskiy, Yuriy Blagova, Olga Kukleva, Anna Semyonova, Lyudmila Gretsov, Evgeniy Ergeshov, Atadzhan |
author_sort | Kogan, Evgeniya |
collection | PubMed |
description | BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in patients with severe coronavirus infection (COVID-19). METHODS: Autopsy data of eight elderly patients (75.6 ± 7.4 years), four male and four female, with severe new coronavirus infection were studied. The lifetime diagnosis of COVID-19 is based on a positive result of the PCR study. The inclusion criterion was the presence of morphological signs of myocarditis according to the Dallas criteria. A standard histological examination included staining by hematoxylin and eosin, toluidin blue and Van Gieson. An immunohistochemical study was performed using antibodies to CD3, CD 68, CD20, perforin, toll-like receptor (TLR) types 4 and 9. PCR in real-time was performed to determine the viral RNA in the myocardium. RESULTS: All patients had severe bilateral viral pneumonia. In all cases, myocarditis was not clinically diagnosed. Morphological examination of the heart found signs of active lymphocytic myocarditis. PCR identified the SARS-Cov2 RNA in all cases. There were also signs of destructive coronaritis in all cases, thrombovasculitis, lymphocytic pericarditis (in 3 cases) and endocarditis (in 2 cases). The absence of neutrophils confirms the aseptic nature of inflammation. An immunohistochemical study showed the CD3-positive T lymphocytes in the infiltrates. Increased expression of TLR type 4 and less 9 was also detected. CONCLUSION: Morphological and immunohistochemical evidence of myocarditis in COVID-19 was presented. Lymphocytic infiltrations and positive PCR confirm the viral nature of inflammation. Myocarditis in COVID-19 is also characterized by coronaritis with microvascular thrombosis and associated with lymphocytic endo- and pericarditis. |
format | Online Article Text |
id | pubmed-8851780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88517802022-02-18 Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 Kogan, Evgeniya Berezovskiy, Yuriy Blagova, Olga Kukleva, Anna Semyonova, Lyudmila Gretsov, Evgeniy Ergeshov, Atadzhan Diagn Pathol Short Report BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in patients with severe coronavirus infection (COVID-19). METHODS: Autopsy data of eight elderly patients (75.6 ± 7.4 years), four male and four female, with severe new coronavirus infection were studied. The lifetime diagnosis of COVID-19 is based on a positive result of the PCR study. The inclusion criterion was the presence of morphological signs of myocarditis according to the Dallas criteria. A standard histological examination included staining by hematoxylin and eosin, toluidin blue and Van Gieson. An immunohistochemical study was performed using antibodies to CD3, CD 68, CD20, perforin, toll-like receptor (TLR) types 4 and 9. PCR in real-time was performed to determine the viral RNA in the myocardium. RESULTS: All patients had severe bilateral viral pneumonia. In all cases, myocarditis was not clinically diagnosed. Morphological examination of the heart found signs of active lymphocytic myocarditis. PCR identified the SARS-Cov2 RNA in all cases. There were also signs of destructive coronaritis in all cases, thrombovasculitis, lymphocytic pericarditis (in 3 cases) and endocarditis (in 2 cases). The absence of neutrophils confirms the aseptic nature of inflammation. An immunohistochemical study showed the CD3-positive T lymphocytes in the infiltrates. Increased expression of TLR type 4 and less 9 was also detected. CONCLUSION: Morphological and immunohistochemical evidence of myocarditis in COVID-19 was presented. Lymphocytic infiltrations and positive PCR confirm the viral nature of inflammation. Myocarditis in COVID-19 is also characterized by coronaritis with microvascular thrombosis and associated with lymphocytic endo- and pericarditis. BioMed Central 2022-02-17 /pmc/articles/PMC8851780/ /pubmed/35177093 http://dx.doi.org/10.1186/s13000-022-01207-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report Kogan, Evgeniya Berezovskiy, Yuriy Blagova, Olga Kukleva, Anna Semyonova, Lyudmila Gretsov, Evgeniy Ergeshov, Atadzhan Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title | Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title_full | Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title_fullStr | Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title_full_unstemmed | Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title_short | Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 |
title_sort | morphologically, immunohistochemically and pcr proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal covid-19 |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851780/ https://www.ncbi.nlm.nih.gov/pubmed/35177093 http://dx.doi.org/10.1186/s13000-022-01207-6 |
work_keys_str_mv | AT koganevgeniya morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT berezovskiyyuriy morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT blagovaolga morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT kuklevaanna morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT semyonovalyudmila morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT gretsovevgeniy morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 AT ergeshovatadzhan morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19 |